Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: LeVine, III, Harry
Article Type: Research Article
Abstract: The second generation of therapeutic strategies for Alzheimer's disease (AD) embraces the Amyloid Hypothesis, which asserts that through a series of events not completely understood, misfolding of the amyloid-β (Aβ) peptide is a primary event eliciting neurodegeneration and AD pathology. A variety of approaches are being tried to interrupt the disease process, including reducing the production of the Aβ peptide, inhibiting its aggregation, and promoting its removal, for example via immunotherapy. The success of anti-Aβ disease-modifying approaches in eliminating the postulated etiologic form(s) of the peptide will ultimately depend on biological clearance and degradation of the various forms of the …Aβ peptide from the brain compartment. Little is known about exchange of theβ peptide between the brain and blood. Increased understanding of this process in experimental animal models and humans, and how it changes with aging, will likely open new therapeutic avenues. It will also be needed to properly design early clinical trials to verify the efficacy of potential drug candidates working through the Aβ peptide. Show more
Keywords: oligomer, proteolysis, aging, misfolded proteins, deposition, peripheral sink
DOI: 10.3233/JAD-2004-6311
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 303-314, 2004
Authors: Miu, Andrei C. | Olteanu, Adrian I. | Miclea, Mircea
Article Type: Research Article
Abstract: The persistence of neuroscientists in exploring aluminium's (Al) possible contribution to the pathogenesis of Alzheimer's disease (AD) has resulted in a wealth of researches detailing the biological toxicity of this metal. However, to date, there have been few accounts of the interference of Al with aging and its relevance to the pathogenesis of AD. We investigated the behavioral and the ultrastructural signatures of Al in the hippocampus on young and aging rats which were exposed for three months to aluminium gluconate. The aging animals displayed decreased scores of activity and emotionality, and the Al-exposed aging males had altered emotional reactivity …behaviors. The electron-microscopic analysis indicated that Al promoted in the aging hippocampus a variety of cellular and ultrastructural degenerative signs, such as granulo-vacuolar degenerations, deposition of lipofuscin and amyloid in the cytoplasm of neurons and astrocytes, and in extracellular compartments, Hirano bodies, demyelination and the atrophy of the mitochondria. Moreover, the quantitation of myelin sheath width and the diameter of mitochondria measured on randomly selected samples confirmed that myelin and mitochondria are primary targets of Al's toxicity. Demyelination and mitochondrial atrophy seemed more advanced in the hippocampus of Al-exposed aging males, supporting the effect of sex suggested by the behavioral results. These findings and other collateral results also reported here are discussed in the context of a possible involvement of Al in AD, mediated by aging and catalyzed by hepatic morphopathology. Show more
Keywords: aluminum, aging, mitochondria, myelin, Alzheimer's disease
DOI: 10.3233/JAD-2004-6312
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 315-328, 2004
Authors: Flicker, L. | Martins, R.N. | Thomas, J. | Acres, J. | Taddei, K. | Norman, P. | Jamrozik, K. | Almeida, O.P.
Article Type: Research Article
Abstract: The ε4 allele of apolipoprotein E (APOE), and the plasma levels of APOE, amyloid β-protein precursor, amyloid β1-40 (Aβ40) and homocysteine (Hcy) have all been correlated with the presence of dementia. Mutations in the methylnetetrahydrofolate reductase enzyme (MTHFR) have been associated with elevated levels of Hcy. This study explored the association of these factors with cognition and depression in community dwelling older men. Two hundred and ninety-nine men, mean age 78.9 years (SD 2.8), were studied in this cross-sectional survey. Mean plasma Hcy was 13.5 (SD 5.3) μmol/L. The MTHFR genotype had no obvious impact on Hcy levels. Ln …Hcy and Ln Aβ40 were both inversely correlated with calculated glomerular filtration rate (cGFR), r = -0.41 (p < 0.001) and r = -0.28 (p < 0.001), respectively. There was a positive correlation between Ln Hcy and Ln Aβ40, r = 0.19 (p < 0.001), which remained significant after adjusting for cGFR, with a doubling of Hcy associated with a 24% increase of Aβ40. The e4 allele was associated with increased depressive symptoms as measured by the Geriatric Depression Scale-15, Odds ratio (OR) = 2.59 (95%CI 1.06–6.34) and poorer performance on the Clock Drawing Test, OR = 2.32 (95% CI: 1.25–4.29). There was a positive association between Aβ40 and Hcy, even after adjustment for cGFR in this sample of well, community dwelling older men. This association may help elucidate the link between elevated levels of Hcy and Alzheimer's disease. Show more
Keywords: dementia, amyloid protein, Apolipoprotein E, cognition, depression, homocysteine, methylnetetrahydrofolate reductase, geriatric
DOI: 10.3233/JAD-2004-6313
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 329-336, 2004
Article Type: Discussion
DOI: 10.3233/JAD-2004-6314
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 337-342, 2004
Article Type: Other
DOI: 10.3233/JAD-2004-6315
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 343-343, 2004
Article Type: Obituary
DOI: 10.3233/JAD-2004-6316
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 345-345, 2004
Article Type: Announcement
DOI: 10.3233/JAD-2004-6317
Citation: Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 347-352, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl